AMRN - Amarin Corp PLC Stock Price, Fair Value and News

$10.62-0.29 (-2.66%)
Delayed as of 05 May 2025, 11:57 am ET
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

AMRN Price Action

Last 7 days

4.6%


Last 30 days

26.9%


Last 90 days

-5.9%


Trailing 12 Months

-40.7%

AMRN Stock Price

AMRN RSI Chart

AugSepOctNovDec2025FebMarAprMay102030405060708090100

AMRN Valuation

Market Cap

4.5B

Price/Earnings (Trailing)

-54.64

Price/Sales (Trailing)

19.64

EV/EBITDA

-56.6

Price/Free Cashflow

-144.76

AMRN Price/Sales (Trailing)

202220232024202510203040506070

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

AMRN Fundamentals

AMRN Revenue

Revenue (TTM)

228.6M

Rev. Growth (Yr)

-16.61%

Rev. Growth (Qtr)

47.3%

2014201620182020202220240100M200M300M400M500M600M

AMRN Earnings

Earnings (TTM)

-82.2M

Earnings Growth (Yr)

-741%

Earnings Growth (Qtr)

-93.44%

20102012201420162018202020222024-400M-300M-200M-100M0

AMRN Profitability

EBT Margin

-33.77%

Return on Equity

-16.9%

Return on Assets

-11.99%

Free Cashflow Yield

-0.69%

AMRN Investor Care

Shares Dilution (1Y)

0.96%

Diluted EPS (TTM)

-0.2

Revenue Breakdown

As of: Dec 31, 2024
2018201920202021202220232024020M40M60M80M100M120M
Product
ProductValuePercent
BusinessValuePercent
TotalValuePercent

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
2014201620182020202220240100M200M300M400M500M600M
Net sales
YearQ1Q2Q3Q4
2024277.5M264.8M241.0M228.6M
2023360.5M346.3M322.4M306.9M
2022535.6M475.6M423.4M369.2M
2021601.2M620.4M605.9M583.2M
2020511.5M546.0M590.1M614.1M
2019258.6M306.7M363.8M429.8M
2018190.4M197.8M205.8M229.2M
2017139.2M151.3M165.9M181.1M
201691.4M106.8M118.0M130.1M
201559.2M64.3M71.6M81.8M
201435.0M42.1M47.8M54.2M
201300026.4M
Get all data in R, Python etc through our Historical Stock Data APIs
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
 CEO
 WEBSITEamarincorp.com
 SECTORHealthcare
 INDUSTRYDrug Manufacturers General
 EMPLOYEES365

Amarin Corp PLC Frequently Asked Questions


What is the ticker symbol for Amarin Corp PLC? What does AMRN stand for in stocks?

AMRN is the stock ticker symbol of Amarin Corp PLC. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Amarin Corp PLC (AMRN)?

As of Fri May 02 2025, market cap of Amarin Corp PLC is 4.49 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AMRN stock?

You can check AMRN's fair value in chart for subscribers.

Is Amarin Corp PLC a good stock to buy?

The fair value guage provides a quick view whether AMRN is over valued or under valued. Whether Amarin Corp PLC is cheap or expensive depends on the assumptions which impact Amarin Corp PLC's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AMRN.

What is Amarin Corp PLC's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 02 2025, AMRN's PE ratio (Price to Earnings) is -54.64 and Price to Sales (PS) ratio is 19.64. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AMRN PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Amarin Corp PLC's stock?

In the past 10 years, Amarin Corp PLC has provided -0.117 (multiply by 100 for percentage) rate of return.